The Lupus prEGnAnCY Cohort: An International Prospective Cohort of Lupus Pregnancies
Studying Systemic lupus erythematosus
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Principal Investigator
- Evelyne Vinet, MD/PhDResearch Institute of the McGill University Health Centre
- Enrollment
- 100 enrolled
- Eligibility
- 18-45 years · FEMALE
- Timeline
- 2018 – 2024
Study locations (1)
- McGill University Health Centre, Montreal, Quebec, Canada
Collaborators
Duke University · University of California, Los Angeles · Dalhousie University · Hanyang University · Hospital for Special Surgery, New York · Johns Hopkins University · Monash University · New York University · Oklahoma Medical Research Foundation · University of North Carolina · Temple University · University of Alabama at Birmingham · University of Birmingham · University of Calgary · University of California · University of Copenhagen · University of Manitoba · University of Michigan · University of Toronto · NYU Langone Health · University of British Columbia · National Institute of Medical Science & Nutrition · Laval University · University Health Network, Toronto
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03746028 on ClinicalTrials.govOther trials for Systemic lupus erythematosus
Additional recruiting or active studies for the same condition.
- RECRUITINGEARLY PHASE1NCT07107659Safety and Efficacy of ONT01 in LupusHospital for Special Surgery, New York
- RECRUITINGNANCT07558850Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune DiseasesThe First Affiliated Hospital with Nanjing Medical University
- RECRUITINGNCT06948110Deciphering the Genetic Architecture of Autoimmune DiseasesNational Human Genome Research Institute (NHGRI)
- RECRUITINGPHASE2NCT07409181A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)Boehringer Ingelheim
- RECRUITINGPHASE3NCT07332481A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic DiseaseEMD Serono Research & Development Institute, Inc.
- RECRUITINGEARLY PHASE1NCT07526350MTS109 in Patients With Refractory Autoimmune DiseasesShanghai Changzheng Hospital
- RECRUITINGEARLY PHASE1NCT07490041Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic DiseasesThe Children's Hospital of Zhejiang University School of Medicine
- RECRUITINGNANCT07470151Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune DiseasesUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology